This is the thing, they all think we're stupid," "Okay.

New Post Public Reply Private Reply Replies (0) Message Board
dw
182
This is the thing, they all think we're stupid,"
"Okay. Sure. I'm going to lend you $125 million and not know about it. Or not be aware," he said, laughing.

Don Hankey of Knight Specialty Insurance swears he's never met or spoken to Donald Trump, but former Republican Party chairman Michael Steele isn't buying it.
Hankey helped arrange Trump's $175 million bond, Bloomberg News reported. The man is also the biggest share holder in Axos, the bank that refinanced Trump Tower.

"Yes, I voted for him in the past, but this is a business deal and this is what we do," Hankey told Bloomberg. "I have never met Donald Trump, nor talked to him on the phone."

While there would be nothing illegal or underhand if Hankey did know Trump and gave him funds, Steele questioned his claim.

MSNBC host Nicolle Wallace pointed to former FBI agent Peter Strzok's book, Compromised: Counterintelligence and the Threat of Donald J. Trump, in which he wrote there are "geopolitical and national security concerns in question ... where a president's money comes from."

She pointed out that there are ethical questions at a time when Trump is running for president.

Wallace said that NBC News outlined two loans that Axos gave Trump, together totaling over $225 million. Steele didn't believe that Hankey was unaware of the loans from Axos.

"Okay. Sure. I'm going to lend you $125 million and not know about it. Or not be aware," he said, laughing.


"This is the thing, they all think we're stupid," Steele continued. "They'll put this out in the ether and we'll say, 'Okay, that makes sense.' There is a reason why 30-some-odd other banks and surety firms said no. And so there has to be a reason why he said yes. And that is because — especially because — he's running for president."

Steele also agreed that it was essential to know if there was a deal between the two men in exchange for the funds.

"Again, this is only $175 million of a $454 million judgment," he explained. "So, the question still remains: what happens to the other, you know, $270 some million dollars that is not being discussed right now? There is that piece.

"Is there some back deal to sort of cover that down the road? How is this deal put together? And that level of scrutiny has to be a part of this conversation. I'm sorry you just cannot get away with, 'Oh, well I never met the guy, I've never really talked to him. But I've given him over $100 million three times. Stop.


'They think we're stupid': Ex-GOP chair doesn't buy claims from man who paid Trump's bond
youtu.be


Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dermatology Access Expands in Kansas With Expert Return

Updated Category News Views 23

Jenna King's Return Elevates Local Care Who says you can't go home again? Jenna King, a familiar face in Southeast Kansas, is back to serve her community by upping the ante in dermatology care at U.S. Dermatology Partners in Pittsburg. After gaining experience in Oklahoma, she's here to extend both medical and cosmetic treatments to her neighbors. Why Her Return Is a Game...

Continue Reading
Direxion Targets Anthropic's IPO with Bold New ETFs

Updated Category News Views 40

Anthropic's IPO Sparks Direxion's Latest ETF Moves Alright, folks, Anthropic's public filing for an IPO isn't just turning heads—it's lighting up the trading floor! Following this buzz, Direxion grabs its chance to unleash two new ETFs designed to seize on Anthropic's rollercoaster debut. We're talking about the Direxion Daily Anthropic Bull 2X ETF (ANTO) and the...

Continue Reading
Aker BP's Q3 2026: Strong Earnings Fuel Optimism

Updated Category News Views 126

Third Quarter Overview: Riding the Wave Aker BP's third quarter report is a raucous symphony of successes that have the market nodding in admiration. Marking significant strides with their offshore projects, the company seems to be in a cavalier mood as it boasts higher sales volumes and promising financials. Net production came in at 374 mboepd, dampened slightly by...

Continue Reading
Entangled 2026 Summit: Driving Quantum, AI, & Biotech Synergy

Updated Category News Views 36

What's Brewing at Entangled 2026? Innovation's got a new haunt come November, and it’s sprouting right in Cambridge's Kendall Square. LabCentral, C10 Labs, and Innovation Centre Denmark Boston have concocted something here for the curious minds: Entangled 2026. Picture over 250 movers and shakers from biotech, deep tech, investment, academia, and more, gathering under...

Continue Reading
Pozdeutinurad Phase 3 Success Impact on Sobi and Market

Updated Category News Views 70

Pozdeutinurad's Phase 3 Triumph Ah, the life of biotech—constant ups and downs, but when you hit a homerun, it feels like the market stands still for a second. Pozdeutinurad's recent Phase 3 REDUCE-2 study results are one of those moments for Swedish Orphan Biovitrum AB, or Sobi for short. This study showed some seriously compelling data: clinically meaningful and...

Continue Reading
P.S. Active Teams with Barrett for Logistics Boost

Updated Category News Views 9

Barrett Gets in the Game with P.S. Active Alright, picture this: an activewear brand hooked up with a logistics heavyweight. No, it's not just another round of corporate muscle-flexing—it's P.S. Active, spearheaded by Erika Hammond, partnering with Barrett Distribution Centers to elevate their fulfillment game from New Jersey's Somerset hub. The Stakes: More Than Just...

Continue Reading
Fan Creations Shine: McLaren's Unique Livery Unveiled

Updated Category News Views 98

From Sticker Dreams to Racing Reality Some days bring surprises outside the typical ticker watch as those market charts get shoved aside, right when fans' stories race onto the scene. What McLaren and Velo cooked up for the Mexico City Grand Prix has got me pausing—a blend of motorsport passion and grassroots creativity. By unveiling the 'Livery of Dreams,' McLaren puts...

Continue Reading
ServiceNow Faces Legal Probe Amid Stock Slide

Updated Category News Views 52

Stock Turbulence Hits ServiceNow Investors Wake up and smell the market correction! ServiceNow's done slapped its shareholders with a situation no one saw coming—or maybe not. When the market opened on October 29, NYSE:NOW shares weren't just dipping; they were diving off a $29 cliff, all thanks to some sour guidance for fourth-quarter growth. Talk about financial...

Continue Reading
Cat Financial Shows Solid Q3 Growth Amid Challenges

Updated Category News Views 82

Healthy Gains in Revenues and Profits Well, Cat Financial's latest report is another piece of the puzzle showing steady, if not spectacular, growth. They've jacked up their revenues by 10% for the third quarter of 2026 compared to last year's same stretch. This puts the revenues at $1.02 billion, a $95 million bump from the previous year. Pretty impressive. The profit saw...

Continue Reading
Busch Gardens' Holiday Extravaganza Lights Up 2026

Updated Category News Views 30

A Dazzling Holiday Transformation Awaits Forget the mundane holiday light displays. Busch Gardens is cranking it up a notch with their annual Christmas Town spectacle, kicking off on November 13. With two parks—Tampa Bay and Williamsburg—each delivering a unique experience, prepare for an immersive dive into holiday cheer that's packed with glitz, entertainment, and,...

Continue Reading

Top 5 Most Recently Viewed Articles

PharmaTher's Bold Plans for Ketamine Market Domination

Updated Category News Views 127

PharmaTher's Roadmap to Ketamine Commercialization PharmaTher Holdings Ltd. (the "Company" or "PharmaTher") (OTCQB: PHRRF) (CSE: PHRM), a pioneering specialty pharmaceutical firm, is steering its focus towards the development and commercialization of ketamine-based therapies. The Company has carved out an impressive path for itself as it aspires to lead in unlocking the...

Continue Reading
Causum's Mars® Emerges as Key AI Governance Tool for Firms

Updated Category News Views 175

The Rise of AI Governance in a Chaotic Landscape Here we are, on the cusp of a tech revolution where regulations are starting to tighten around AI like a vise. You remember those wild days back during the dot-com boom, right? Everyone was scrambling to cash in on tech, while the ground rules were still being drawn up. Well, history's repeating itself—only this time,...

Continue Reading
Parsons Corporation to Share Insights at Key Financial Conference

Updated Category News Views 309

Parsons Corporation's Upcoming Conference Presentation Parsons Corporation will soon take the stage at a significant financial event known as the Raymond James 46th Annual Institutional Investors Conference. This prestigious conference is an excellent opportunity for the company to engage with investors and provide insights into its strategic direction. Featured Speakers...

Continue Reading
Innovative Mud Cleaning Tool Revolutionizes Home Renovations

Updated Category News Views 213

Revolutionizing Mud Pan Cleaning with Innovative Design Meet a groundbreaking solution for home renovation enthusiasts and professionals alike—an inventive tool designed specifically for cleaning mud pans efficiently and effectively. This innovative product stems from the extensive experience of a skilled drywall finisher who spent 40 years in the industry, identifying...

Continue Reading
Brookfield Asset Management Achieves New Heights with BAM Stock

Updated Category News Views 108

Brookfield Asset Management Achieves New Heights with BAM Stock Brookfield Asset Management Inc (TSX: BAM) recently celebrated a major milestone as its stock reached an impressive 52-week high of $47.45. This achievement demonstrates the company’s strong growth trajectory and effective strategies in place. Investors are showing increased confidence in BAM’s unique...

Continue Reading